GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (WBO:COLO) » Definitions » Accounts Payable & Accrued Expense

Coloplast AS (WBO:COLO) Accounts Payable & Accrued Expense : €533 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Accounts Payable & Accrued Expense?

Coloplast AS's quarterly accounts payable & accrued expense increased from Sep. 2024 (€645 Mil) to Dec. 2024 (€706 Mil) but then declined from Dec. 2024 (€706 Mil) to Mar. 2025 (€533 Mil).

Coloplast AS's annual accounts payable & accrued expense increased from Sep. 2022 (€689 Mil) to Sep. 2023 (€1,176 Mil) but then declined from Sep. 2023 (€1,176 Mil) to Sep. 2024 (€645 Mil).

Coloplast AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for Coloplast AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Accounts Payable & Accrued Expense Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 468.00 511.57 689.01 1,176.26 645.10

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 675.54 690.56 645.10 705.58 533.47

Coloplast AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Coloplast AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (WBO:COLO) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
OCSE:DEMANT OCSE:AMBU B OCSE:EMBLA OCSE:GN OCSE:CHEMM OCSE:SMSMED OCSE:VIRO ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 XPAR:DIM XSWX:STMN COO BAX WST NZSE:FPH
Traded in Other Exchanges
CLPBY:USA CLPBF:USA 0QBO:Mexico COLOBc:UK 0QBO:UK COLO B:Denmark CBHD:Germany
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Website
https://www.coloplast.com
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines